39 completed. 39 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 39 | Completed 39 |
Follow Leukemia, Lymphoid: new trials by email Literature Review of Leukemia, Lymphoid trials Research Report on Leukemia, Lymphoid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery Bridion 200 MG in 2 ML Injection, Pyridostigmine Bromide 5 MG/ML - Emergence Delirium, Strabismus | Phase 4 | Completed | Konkuk University Medical Center | 76 | 2023-12-01 | 2026-07-15 |
| A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia inotuzumab ozogamicin - Acute Lymphoblastic Leukemia | Phase 4 | Completed | Pfizer | 44 | 2023-02-24 | 2025-12-03 |
| Acalabrutinib Study in Indian Patients With Chronic Lymphocytic Leukaemia & Relapsed and Refractory Mantle Cell Lymphoma Acalabrutinib capsule - Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma | Phase 4 | Completed | AstraZeneca | 103 | 2021-07-14 | 2024-11-22 |
| Nalbuphine Versus Ketamine for Prevention of Emergence Agitation After Sevoflurane in Children Undergoing Tonsillectomy Nalbuphine Injection, Ketamine, Saline - Pediatric ALL, Pediatric Anesthesia | Phase 4 | Completed | Ain Shams University | 90 | 2021-03-25 | 2022-01-04 |
| Regional Anesthesia for Totally Awake Upper Limb Surgery in PEDiatric Population local anaesthetic injection - Surgery, Anesthesia, Local | Phase 4 | Completed | GCS Ramsay Santé pour l'Enseignement et la Recherche | 100 | 2020-10-14 | 2026-07-16 |
| A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients inotuzumab ozogamicin-dose level 2, Inotuzumab ozogamicin-dose level 1 - Leukemia, Precursor b-Cell Lymphoblastic Leukemia-Lymphoma | Phase 4 | Completed | Pfizer | 102 | 2019-07-01 | 2023-11-22 |
| A Study to Assess Safety of ImbruvicaTM in Indian Participants With Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy or Chronic Lymphocytic Leukemia With 17p Deletion Ibrutinib 420 mg, Ibrutinib 560 mg - Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell | Phase 4 | Completed | Johnson & Johnson Private Limited | 75 | 2019-06-26 | 2025-05-25 |
| Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric ECMO Bivalirudin, Unfractionated heparin - Extracorporeal Membrane Oxygenation Complication, Pediatric ALL | Phase 4 | Completed | University of Texas Southwestern Medical Center | 30 | 2018-03-25 | 2023-01-31 |
| MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study MP Diagnostics HTLV Blot 2.4 - HTLV-I Infections, HTLV-II Infections | Phase 4 | Completed | MP Biomedicals, LLC | 150 | 2018-01-15 | 2018-09-13 |
| A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT Vitamin D3, Standard Vitamin D3 Supplementation - Vitamin D Deficiency, Stem Cell Transplant Complications | Phase 4 | Completed | Phoenix Children's Hospital | 49 | 2017-11-01 | 2020-11-17 |
| Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge budesonide, beclomethasone - Asthma, Pediatric ALL | Phase 4 | Completed | New York City Health and Hospitals Corporation | 43 | 2017-09-10 | 2019-07-18 |
| Vaccinating Children After Chemotherapy Prevnar®13, Pneumovax® 23, Pediacel® - Acute Lymphoblastic Leukemia | Phase 4 | Completed | Canadian Immunization Research Network | 156 | 2015-11-16 | 2022-06-24 |
| The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and Adolescents PEG-rhG-CSF - Acute Lymphoid Leukemia | Phase 4 | Completed | Chinese Academy of Medical Sciences | 9 | 2015-09-01 | 2016-11-03 |
| Comparision of the Use in Marcaine and Chloroprocaine in Rachianesthesia for the Surgical Correction of Inguinal Hernia. Chloroprocaine, Marcaine - Pain | Phase 4 | Completed | Astes | 50 | 2013-11-01 | 2014-11-03 |
| Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study Nilotinib - Chronic Myelogenous Leukemia (CML), Metastatic Gastrointestinal Stromal Tumors (GIST) | Phase 4 | Completed | Novartis Pharmaceuticals | 57 | 2013-03-29 | 2024-02-08 |
| Antiviral Treatment of Chronic Lymphocytic Leukemia Valganciclovir - Chronic Lymphocytic Leukemia | Phase 4 | Completed | Medical University of Vienna | 20 | 2010-12-01 | 2015-07-21 |
| Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia Cyclophosphamide, Doxorubicin, Vincristine - Acute Lymphoblastic Leukemia | Phase 4 | Completed | Ruijin Hospital | 100 | 2010-12-01 | 2014-05-20 |
| A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe) bendamustine, chlorambucil, rituximab [MabThera/Rituxan] - Lymphocytic Leukemia, Chronic | Phase 4 | Completed | Hoffmann-La Roche | 357 | 2010-03-01 | 2015-06-25 |
| The Duration of Humoral Immunity and the Memory Cell Function After Vaccination With 7-valent Pneumococcal Conjugate Vaccine in CLL Pneumococcal polysaccharide vaccine (PPV) - Chronic Lymphocytic Leukemia (CLL) | Phase 4 | Completed | Tampere University Hospital | 32 | 2009-06-01 | 2014-02-19 |
| Efficacy and Safety of Ofatumumab Retreatment and Maintenance Treatment in Patients With B-cell Chronic Lymphocytic Leukemia (CLL) Ofatumumab - Leukaemia, Lymphocytic, Chronic | Phase 4 | Completed | GlaxoSmithKline | 29 | 2009-01-01 | 2014-05-14 |
Showing 20 of 39. Sign in to see all of them.
Precursor Cell Lymphoblastic Leukemia-Lymphoma (30) · Leukemia, Lymphocytic, Chronic, B-Cell (8) · Lymphoma (3) · Lymphoma, Mantle-Cell (3) · Myelodysplastic Syndromes (3) · Neoplasm, Residual (3) · Recurrence (3) · Burkitt Lymphoma (2) · Emergence Delirium (2) · Leukemia (2) · Lymphoma, Non-Hodgkin (2) · Neoplasms, Plasma Cell (2) · Anemia (1) · Anemia, Aplastic (1) · Asthma (1)
Hemic and Lymphatic Diseases (39) · Immune System Diseases (39) · Immunoproliferative Disorders (39) · Lymphatic Diseases (39) · Lymphoproliferative Disorders (39) · Neoplasms by Histologic Type (39) · Hematologic Diseases (38) · Neoplasms (38) · Leukemia (37) · Pathological Conditions, Signs and Symptoms (16) · Pathologic Processes (15) · Disease Attributes (10) · Chronic Disease (9) · Leukemia, B-Cell (7)
Vincristine (15) · Cyclophosphamide (14) · Cytarabine (14) · Methotrexate (13) · Dexamethasone (12) · Mercaptopurine (12) · Asparaginase (11) · Daunorubicin (10) · Doxorubicin (8) · Prednisolone (8) · Etoposide (6) · Granulocyte Colony-Stimulating Factor (6) · Teniposide (6) · Prednisone (5) · Rituximab (5)
Goethe University (5) · PETHEMA Foundation (5) · Johann Wolfgang Goethe University Hospital (2) · Pfizer (2) · Ain Shams University (1) · Astes (1) · AstraZeneca (1) · Canadian Immunization Research Network (1) · Charite University, Berlin, Germany (1) · Chinese Academy of Medical Sciences (1) · GCS Ramsay Santé pour l'Enseignement et la Recherche (1) · Genzyme, a Sanofi Company (1) · GlaxoSmithKline (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · Hoffmann-La Roche (1)
Germany (10) · United States (9) · Spain (8) · Austria (3) · China (3) · France (3) · Hungary (3) · India (3) · Sweden (3) · Belgium (2) · Canada (2) · Finland (2) · Italy (2) · Singapore (2) · South Korea (2)
Dieter Hoelzer, MD,PhD (4) · Bastida Pilar, Dr (2) · Dieter Hoelzer, MD, PhD (2) · Alexander Ngwube, MD (1) · Ali McMichael, MD (1) · Barry R. Meisenberg, MD (1) · Christoph Steininger, MD (1) · Dieter Hoelzer, MD (1) · Edina Magyarosy, MD (1) · Eduardo Dibar, MD (1) · Eric P Deflandre, MD, FCCP (1)
PMID 19144982, PMID 22442346, PMID 22493293, PMID 23024237, PMID 27561722, PMID 28751559, PMID 14752084, PMID 15014526, PMID 15158091, PMID 15257960, PMID 17223475, PMID 19564304, PMID 21828124, PMID 21940824, PMID 22198540, PMID 23775972, PMID 24752047, PMID 25253770, PMID 25359988, PMID 26001791, PMID 26377300, PMID 29420116, PMID 31644328, PMID 32067048, PMID 33305842, PMID 33875811, PMID 34010787, PMID 35622074, PMID 35911824, PMID 39585174, PMID 39882642, PMID 42477805, PMID 42787222
2009 (2), 2018 (1), 2019 (1), P30CA021765 (1), R01CA078957 (1), U01CA081445 (1)